BioLineRx Ltd. Logo

BioLineRx Ltd.

A clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases.

BLRX | TA

Overview

Corporate Details

ISIN(s):
US09071M2052 (+1 more)
LEI:
529900AKIOSC15Y63R18
Country:
Israel
Address:
Modi'in Technology Park, 2 HaMa'ayan Street, 7177871 Modi'in

Description

BioLineRx Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for oncology and rare diseases. The company leverages its drug development capabilities to advance novel, early-stage therapeutic candidates through the clinical development process toward regulatory approval. Its pipeline consists of treatments, including small molecules, designed to address unmet medical needs and deliver meaningful benefits to patients. BioLineRx also partners with other drug developers to advance their early-stage programs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2017-03-31 01:49
Immediate Report
English 37.2 KB
2017-03-29 15:58
Other Report or Announcement
English 155.1 KB
2017-03-29 15:58
Other Report or Announcement
English 37.5 KB
2017-03-27 17:58
Other Report or Announcement
English 159.1 KB
2017-03-27 17:58
Other Report or Announcement
English 37.4 KB
2017-03-23 14:59
Report of Periodic or Interim Report
English 1.7 MB
2017-03-23 14:59
Report of Periodic or Interim Report
English 37.2 KB
2017-03-23 14:56
Report of Periodic or Interim Report
English 223.5 KB
2017-03-23 14:56
Report of Periodic or Interim Report
English 37.3 KB
2017-03-23 13:58
Immediate Report
English 164.8 KB
2017-03-23 13:58
Immediate Report
English 37.2 KB
2017-03-20 13:57
Other Report or Announcement
English 173.9 KB
2017-03-20 13:57
Other Report or Announcement
English 37.4 KB
2017-03-09 17:12
Other Report or Announcement
English 79.1 KB
2017-03-09 17:12
Other Report or Announcement
English 37.4 KB

Automate Your Workflow. Get a real-time feed of all BioLineRx Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioLineRx Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioLineRx Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CG Invites Co., Ltd. Logo
A biopharmaceutical company specializing in digital genomics and personalized medicine.
South Korea
083790
CG Oncology, Inc. Logo
Develops bladder-sparing oncolytic immunotherapies for urologic cancers.
United States of America
CGON
CHA Vaccine Research Institute Logo
Develops vaccines and immunotherapeutics using proprietary adjuvant platforms.
South Korea
261780
Develops and manufactures veterinary medicines and functional feed additives.
South Korea
052670
Chemical Works of Gedeon Richter Plc Logo
Vertically integrated pharma company focused on women's health and other therapies.
Hungary
RICHT
Chemomab Therapeutics Ltd. Logo
Clinical-stage biotech developing therapeutics for fibro-inflammatory diseases.
United States of America
CMMB
CHINA PHARMA HOLDINGS, INC. Logo
Develops, manufactures, and markets prescription, OTC, and nutritional products.
United States of America
CPHI
China SXT Pharmaceuticals, Inc. Logo
Researches, develops, manufactures, and sells traditional Chinese medicine products.
United States of America
SXTC
ChoA Pharmaceutical Co., LTD. Logo
Develops, manufactures, and sells pharmaceutical products and health supplements.
South Korea
034940
Chong Kun Dang Pharmaceutical Corp. Logo
Develops and manufactures drugs for systemic anti-infectives and metabolic diseases.
South Korea
185750

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.